Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2001 | 09-2000 | 09-1999 | 09-1998 | 09-1997 | |
| Sales | 0 | 100 | 2,080 | 6,120 | 6,153 |
| Gross Profit | N/A | 100 | 2,080 | 6,120 | 6,153 |
| Operating Expenses | 8,089 | 10,250 | 22,030 | 20,290 | 0 |
| Operating Income | -8,089 | -10,150 | -19,950 | -14,170 | 6,153 |
| Other Income | -11,660 | 3,490 | 360 | -4,970 | -16,232 |
| Pre-tax Income | -19,749 | -6,660 | -19,590 | -19,140 | -10,079 |
| Net Income Continuous | -19,749 | -6,339 | -19,598 | -13,846 | -17,803 |
| Net Income Discontinuous | -2,464 | 0 | 0 | 0 | 0 |
| Net Income | $-22,213 | $-6,660 | $-19,590 | $-19,140 | $-10,079 |
| EPS Basic Total Ops | -27.80 | -10.60 | -29.80 | -26.90 | -14.50 |
| EPS Basic Continuous Ops | -24.80 | -10.04 | -29.77 | -19.47 | -25.65 |
| EPS Basic Discontinuous Ops | -3.00 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -27.80 | -10.60 | -29.80 | -26.90 | -25.50 |
| EPS Diluted Continuous Ops | -24.80 | -10.04 | -29.77 | -19.47 | -25.50 |
| EPS Diluted Discontinuous Ops | -3.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,925 | $-9,890 | $-19,180 | $-12,340 | $6,153 |